Provided by Tiger Fintech (Singapore) Pte. Ltd.

Silence Therapeutics Plc

2.61
-0.1300-4.74%
Post-market: 2.610.00000.00%16:22 EDT
Volume:239.38K
Turnover:602.93K
Market Cap:123.26M
PE:-2.66
High:2.74
Open:2.50
Low:2.39
Close:2.74
Loading ...

European Equities Traded in the US as American Depositary Receipts Plunge in Friday Trading

MT Newswires Live
·
04 Apr

Publication of Data from Prospective, Multicenter Study Demonstrates Positive Survival Outcomes in Patients with Low-Risk Melanoma Who Avoided Sentinel Lymph Node Biopsy with Information from Castle Biosciences’ DecisionDx®-Melanoma Test

GlobeNewswire
·
03 Apr

Silence Therapeutics plc (NASDAQ:SLN): When Will It Breakeven?

Simply Wall St.
·
02 Apr

Castle Biosciences to Present New Data at EADO Supporting the Clinical Value of the DecisionDx®-Melanoma Test in Guiding Risk-Aligned Management of Patients with Melanoma

GlobeNewswire
·
02 Apr

European Equities Traded in the US as American Depositary Receipts Tread Water in Tuesday Trading

MT Newswires Live
·
01 Apr

Castle Biosciences' DecisionDx®-SCC Data Earns Top Five Abstract at NCCN 2025, Shows Significantly Enhanced Risk Stratification Beyond Current Staging Within NCCN Risk Groups

GlobeNewswire
·
29 Mar

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

MT Newswires Live
·
25 Mar

European Equities Traded in the US as American Depositary Receipts Tread Water in Thursday Trading

MT Newswires Live
·
13 Mar

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Up Slightly for Week

MT Newswires Live
·
08 Mar

New Data to be Presented at the 2025 American Academy of Dermatology (AAD) Annual Meeting Further Strengthens Evidence Supporting the Clinical Value of Castle Biosciences' Dermatology Portfolio

Business Wire
·
07 Mar

Revenue Downgrade: Here's What Analysts Forecast For Silence Therapeutics plc (NASDAQ:SLN)

Simply Wall St.
·
06 Mar

Silence Therapeutics to Webcast Presentation at the Leerink Partners Global Healthcare Conference

Business Wire
·
05 Mar

Silence Therapeutics (SLN) Upgraded to Buy: Here's What You Should Know

Zacks
·
05 Mar

Silence Therapeutics Is Maintained at Sell by Goldman Sachs

Dow Jones
·
04 Mar

Silence Therapeutics Plc Earnings Call Highlights Progress and Challenges

TIPRANKS
·
04 Mar

Silence Therapeutics Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.
·
01 Mar

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Remain Flat for Week

MT Newswires Live
·
01 Mar

Analysts Offer Insights on Healthcare Companies: Keros Therapeutics (KROS), Kura Oncology (KURA) and Silence Therapeutics (SLN)

TIPRANKS
·
28 Feb

Analysts Are Bullish on These Healthcare Stocks: Silence Therapeutics (SLN), Warby Parker (WRBY)

TIPRANKS
·
28 Feb

Silence Therapeutics FY EPS $(0.33) Up From $(0.49) YoY, Sales $43.26M Up From $31.64M YoY

Benzinga
·
27 Feb